Man Group plc - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$3,659,000
+63.4%
30,897
+41.0%
0.02%
+45.5%
Q2 2020$2,239,000
+45.8%
21,912
+53.9%
0.01%
+10.0%
Q1 2020$1,536,000
-91.5%
14,234
-90.8%
0.01%
-83.3%
Q4 2019$18,103,000
+143.0%
155,561
+139.0%
0.06%
+114.3%
Q3 2019$7,451,000
+62.2%
65,092
+7.5%
0.03%
+40.0%
Q4 2018$4,595,000
+6.1%
60,540
+11.9%
0.02%
+25.0%
Q3 2018$4,330,000
-45.5%
54,120
-32.4%
0.02%
-51.5%
Q2 2018$7,950,00080,0370.03%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2018
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 627,111$74,068,00020.20%
Athos Capital Ltd 362,909$42,863,00011.81%
PSquared Asset Management AG 205,000$24,213,0003.85%
York Capital Management Global Advisors, LLC 302,675$35,749,0003.52%
HHLR ADVISORS, LTD. 2,962,076$349,851,0002.78%
ALPINE ASSOCIATES MANAGEMENT INC. 534,180$63,092,0002.58%
Pentwater Capital Management LP 1,178,000$139,134,0001.68%
Temasek Holdings (Private) Ltd 1,240,000$146,456,0000.63%
AQR Arbitrage LLC 142,733$16,858,0000.59%
FORT, L.P. 9,761$1,153,0000.34%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders